Insider Trading disclosures for Eiger BioPharmaceuticals Inc

The latest disclosure was made by David Apelian in Eiger BioPharmaceuticals Inc where a trade of 750,000 Stock Option (Right to Buy) done was reported to US exchanges on July 3, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
David Apelian	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jul 2023	750,000	750,000	-		-	Stock Option (Right to Buy)
James Vollins	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Apr 2023	120,000	120,000	-		-	Stock Option (Right to Buy)
Eldon C. Mayer	Ex VP & Chief Commerc. Officer	Sale of securities on an exchange or to another person at price $ 1.07 per share.	17 Mar 2023	2,520	57,948 (0%)	0%	1.1	2,696	Common Stock
Eldon C. Mayer	Ex VP & Chief Commerc. Officer	Sale of securities on an exchange or to another person at price $ 1.07 per share.	17 Mar 2023	1,875	56,073 (0%)	0%	1.1	2,008	Common Stock
Amit K. Sachdev	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	28,000	28,000	-		-	Stock Option (Right to Buy)
Lisa Kelly-Croswell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	28,000	28,000	-		-	Stock Option (Right to Buy)
Thomas J. Dietz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	40,000	40,000	-		-	Stock Option (Right to Buy)
Christine Murray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	28,000	28,000	-		-	Stock Option (Right to Buy)
Evan Loh	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	28,000	28,000	-		-	Stock Option (Right to Buy)
Jeffrey S Glenn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	28,000	28,000	-		-	Stock Option (Right to Buy)
Eldon C. Mayer	Ex VP & Chief Commerc. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	98,000	98,000	-		-	Stock Option (Right to Buy)
Kim Sablich	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2023	28,000	28,000	-		-	Stock Option (Right to Buy)
David Apelian	Director, Interim CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2023	170,000	170,000	-		-	Stock Option (Right to Buy)
Eldon C. Mayer	Ex VP & Chief Commerc. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	31,500	31,500	-		-	Stock Option (Right to Buy)
Erik Atkisson	GC & Chief Compliance Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2023	26,750	26,750	-		-	Stock Option (Right to Buy)
Thomas J. Dietz	Director	Purchase of securities on an exchange or from another person at price $ 1.43 per share.	23 Jan 2023	50,000	50,000 (0%)	0%	1.4	71,580	Common Stock
Christine Murray	Director	Sale of securities on an exchange or to another person at price $ 1.22 per share.	29 Dec 2022	5,000	11,000 (0%)	0%	1.2	6,104	Common Stock
Thomas J. Dietz	Director	Sale of securities on an exchange or to another person at price $ 1.17 per share.	22 Dec 2022	22,500	21,000 (0%)	0%	1.2	26,303	Common Stock
Jeffrey S Glenn	Director	Purchase of securities on an exchange or from another person at price $ 1.28 per share.	22 Dec 2022	100,000	182,355 (0%)	0%	1.3	127,950	Common Stock
David Apelian	Director	Sale of securities on an exchange or to another person at price $ 9.81 per share.	16 Aug 2022	5,000	11,000 (0%)	0%	9.8	49,031	Common Stock
Lisa Kelly-Croswell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2022	30,000	30,000	-		-	Stock Option (Right to Buy)
Eldon C. Mayer	Ex VP & Chief Commerc. Officer	Sale of securities on an exchange or to another person at price $ 5.60 per share.	14 Mar 2022	1,657	60,468 (0%)	0%	5.6	9,275	Common Stock
Sriram Ryali	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 5.60 per share.	14 Mar 2022	2,266	41,566 (0%)	0%	5.6	12,683	Common Stock
Eldon C. Mayer	Ex VP & Chief Commerc. Officer	Sale of securities on an exchange or to another person at price $ 4.95 per share.	07 Jan 2022	1,560	46,125 (0%)	0%	5.0	7,722	Common Stock
Erik Atkisson	GC & Chief Compliance Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Sep 2021	180,000	180,000	-		-	Stock Option (Right to Buy)
David A. Cory	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jul 2021	48,750	48,750	-		-	Stock Option (Right to Buy)
Eldon C. Mayer	Ex VP & Chief Commerc. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jul 2021	17,500	17,500	-		-	Stock Option (Right to Buy)
Sriram Ryali	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 Jul 2021	30,000	30,000	-		-	Stock Option (Right to Buy)
Sriram Ryali	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2021	87,000	87,000	-		-	Stock Option (Right to Buy)
Kim Sablich	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Apr 2021	25,000	25,000	-		-	Stock Option (right to buy)
Thomas J. Dietz	Director	Purchase of securities on an exchange or from another person at price $ 8.48 per share.	09 Apr 2021	1,500	36,500 (0%)	0%	8.5	12,720	Common Stock
Thomas J. Dietz	Director	Purchase of securities on an exchange or from another person at price $ 8.50 per share.	09 Apr 2021	1,000	37,500 (0%)	0%	8.5	8,500	Common Stock
Amit K. Sachdev	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	10,000	10,000	-		-	Stock Option (Right to Buy)
Amit K. Sachdev	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	5,000	10,000 (0%)	0%		0	Common Stock
James P. Shaffer	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	11,875	29,296 (0%)	0%		0	Common Stock
James P. Shaffer	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	71,250	71,250	-		-	Stock Option (Right to Buy)
David A. Cory	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	281,000	281,000	-		-	Stock Option (Right to Buy)
David A. Cory	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	47,000	117,846 (0%)	0%		0	Common Stock
Thomas J. Dietz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	20,000	20,000	-		-	Stock Option (Right to Buy)
Thomas J. Dietz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	5,000	35,000 (0%)	0%		0	Common Stock
David Apelian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	5,000	10,000 (0%)	0%		0	Common Stock
David Apelian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	10,000	10,000	-		-	Stock Option (Right to Buy)
Christine Murray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	5,000	10,000 (0%)	0%		0	Common Stock
Christine Murray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	10,000	10,000	-		-	Stock Option (Right to Buy)
Evan Loh	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	10,000	10,000	-		-	Stock Option (Right to Buy)
Evan Loh	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	5,000	10,000 (0%)	0%		0	Common Stock
Evan Loh	Director	Sale of securities on an exchange or to another person at price $ 10.14 per share.	12 Mar 2021	2,000	8,000 (0%)	0%	10.1	20,280	Common Stock
Jeffrey S Glenn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	5,000	76,355 (0%)	0%		0	Common Stock
Jeffrey S Glenn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	10,000	10,000	-		-	Stock Option (Right to Buy)
Stephana Patton	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Mar 2021	11,875	17,948 (0%)	0%		0	Common Stock

Showing 1 to 50 of 301 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Insider Trading disclosures for Eiger BioPharmaceuticals Inc

The latest disclosure was made by David Apelian in Eiger BioPharmaceuticals Inc where a trade of 750,000 Stock Option (Right to Buy) done was reported to US exchanges on July 3, 2023.

Screeners based on Insider Trading and SAST parameters